1. Home >
  2. Investors >
  3. Private Equity Firm >
  4. France >
  5. Andera Partners >
  6. M&A

Andera Partners Mergers & Acquisitions

Andera Partners M&A Summary

In the last 3 years, Andera Partners has acquired 3 companies. It has also invested in 10 others.

In the last 3 years, Andera Partners has exited 14 companies. The Firm’s most common exit type is trade sale (36%). Andera Partners’ largest (disclosed) exit occurred in 2023 when it sold Scalian Group for $1.1B.

Sign-up to view Andera Partners’ full profile and discover more large private equity firm investors just like it.

M&A Summary

  • M&A Total Activity147
    • M&A Buy Activity105
    • M&A Sell Activity42
  • M&A Buy/Sell Connections43

Andera Partners

Andera Partners

2, place Rio de Janeiro,
Paris, 75008
France
+33 1 85 73 64 00
www.anderapartners.com

All (147) Buy (105) Sell (42)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2025-10-22 Imcheck Therapeutics · Life Science
Marseilles, France · www.imchecktherapeutics.com

ImCheck Therapeutics is a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel superfamily of immunomodulators. Its clinical-stage program, ICT01, has been advancing to late-stage trials, demonstrating a unique mechanism of action that modulates both innate and adaptive immunity. These “first-in-class” activating antibodies may deliver superior clinical outcomes compared to first-generation immunotherapy approaches, in particular in rational combinations with immune checkpoint inhibitors and immunomodulatory anti-cancer drugs. Imcheck Therapeutics was founded in 2015 and is based in Marseilles, France.

Advisors: Centerview Partners , Dentons , Goodwin Procter 		- Add-on Acquisition

Ipsen
Advisor: A&O Shearman

Andera Partners PE

Bpifrance Investissement PE

EQT Life Sciences PE

GIMV PE


Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal